National Differences For Pharmacovigilance Requirements In Europe.

Join our webinar on “Navigating Regional Differences in Setting up a Pharmacovigilance System in Europe.” This session will discuss the regulations and guidelines to consider when implementing a pharmacovigilance system in Europe. 

From country-specific reporting requirements to cultural considerations, we will cover the key factors you must consider to ensure compliance and effective pharmacovigilance practices across the region. Whether you’re a pharmaceutical company looking to expand into the European market, or an existing player looking to optimize your pharmacovigilance processes, this webinar will provide valuable insights and practical tips for success.

The webinar will lead by our field experts, who share their experiences and best practices. So let’s dive in and explore the complexities and opportunities of pharmacovigilance in Europe.

Martijn van de Leur

Martijn van de Leur

Chief Operating Officer

Martijn van de Leur has over a decade of experience in the pharmacovigilance and drug safety field. Martijn van de Leur graduated from Radboud University with a specialization in Pathobiology and Oncology. Since 2005, he started to work in the life science industry, concentrating in the pharmacovigilance area. As a senior leader in pharmacovigilance and experienced (Deputy) EU QPPV, Martijn has a broad network within the industry and is a known industry speaker with excellent drug safety experience. Before joining Biomapas, he acted as Global Head of Drug Safety Compliance and Global Head of Drug Safety Technologies at Vifor Pharma, and further back in his career working as Pharmacovigilance Lead at Merck.

Setting up Pharmacovigilance In Europe?

Let’s talk how we can team up to conduct them effectively and ensure smooth processes.

Other content that might interest you:

A History of Pharmacovigilance

A History of Pharmacovigilance

Pharmacovigilance, also known as drug safety surveillance, is the process of monitoring, identifying, and assessing medicinal products' potential...

read more